Exelixis Inc (EXEL)
Exelixis Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Tarsus Pharmaceuticals Inc (TARS)
Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements
Standard Biotools Inc (LAB)
Standard BioTools Reports Third Quarter 2025 Financial Results
Spyre Therapeutics (SYRE)
Spyre Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Vaxcyte Inc (PCVX)
Vaxcyte Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Data from Positive VAX-24 Infant Phase 2 Dose-Finding Study
OmniAb Inc (OABIW)
OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights
Azenta Inc (AZTA)
Azenta Life Sciences Partners with PRECEDE Foundation to Advance Early Detection of Pancreatic Cancer
Viking Therapeutics Inc. (VKTX)
Viking Therapeutics to Participate at Upcoming Investor Conferences
Sight Sciences Inc (SGHT)
Sight Sciences to Present at Two Upcoming Investor Conferences
ImmuCell Corporation (ICCC)
ImmuCell Announces Onboarding of New CEO and Related Management Changes